123 related articles for article (PubMed ID: 9853978)
21. Age and sex impact clozapine plasma concentrations in inpatients and outpatients with schizophrenia.
Ismail Z; Wessels AM; Uchida H; Ng W; Mamo DC; Rajji TK; Pollock BG; Mulsant BH; Bies RR
Am J Geriatr Psychiatry; 2012 Jan; 20(1):53-60. PubMed ID: 21422906
[TBL] [Abstract][Full Text] [Related]
22. Clozapine exposure and the impact of smoking and gender: a population pharmacokinetic study.
Ng W; Uchida H; Ismail Z; Mamo DC; Rajji TK; Remington G; Sproule B; Pollock BG; Mulsant BH; Bies RR
Ther Drug Monit; 2009 Jun; 31(3):360-6. PubMed ID: 19349931
[TBL] [Abstract][Full Text] [Related]
23. Comedication of Valproic Acid Is Associated With Increased Metabolism of Clozapine.
Hommers L; Scharl M; Hefner G; Hohner M; Fischer M; Pfuhlmann B; Deckert J; Unterecker S
J Clin Psychopharmacol; 2018 Jun; 38(3):188-192. PubMed ID: 29620699
[TBL] [Abstract][Full Text] [Related]
24. Repeated ingestion of grapefruit juice does not alter clozapine's steady-state plasma levels, effectiveness, and tolerability.
Lane HY; Jann MW; Chang YC; Chiu CC; Huang MC; Lee SH; Chang WH
J Clin Psychiatry; 2001 Oct; 62(10):812-7. PubMed ID: 11816871
[TBL] [Abstract][Full Text] [Related]
25. Effect of post-mortem changes on peripheral and central whole blood and tissue clozapine and norclozapine concentrations in the domestic pig (Sus scrofa).
Flanagan RJ; Amin A; Seinen W
Forensic Sci Int; 2003 Mar; 132(1):9-17. PubMed ID: 12689746
[TBL] [Abstract][Full Text] [Related]
26. Reversible metabolism of clozapine and clozapine N-oxide in schizophrenic patients.
Chang WH; Lin SK; Lane HY; Wei FC; Hu WH; Lam YW; Jann MW
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):723-39. PubMed ID: 9723115
[TBL] [Abstract][Full Text] [Related]
27. Determination of clozapine, norclozapine, and clozapine-N-oxide in serum by liquid chromatography.
Volpicelli SA; Centorrino F; Puopolo PR; Kando J; Frankenburg FR; Baldessarini RJ; Flood JG
Clin Chem; 1993 Aug; 39(8):1656-9. PubMed ID: 8353952
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of clozapine and its metabolites in hippocampal HT22 cells.
Heiser P; Schüler-Springorum M; Schulte E; Hausmann C; Remschmidt H; Krieg JC; Vedder H
Eur J Pharmacol; 2003 Aug; 476(3):167-72. PubMed ID: 12969762
[TBL] [Abstract][Full Text] [Related]
29. Estimating the size of the effects of co-medications on plasma clozapine concentrations using a model that controls for clozapine doses and confounding variables.
Diaz FJ; Santoro V; Spina E; Cogollo M; Rivera TE; Botts S; de Leon J
Pharmacopsychiatry; 2008 May; 41(3):81-91. PubMed ID: 18484549
[TBL] [Abstract][Full Text] [Related]
30. Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking.
Hasegawa M; Gutierrez-Esteinou R; Way L; Meltzer HY
J Clin Psychopharmacol; 1993 Dec; 13(6):383-90. PubMed ID: 8120151
[TBL] [Abstract][Full Text] [Related]
31. Determination of pharmacokinetic properties of clozapine and norclozapine in Korean schizophrenia patients.
Lee ST; Ryu S; Nam HJ; Lee SY; Hong KS
Int Clin Psychopharmacol; 2009 May; 24(3):139-44. PubMed ID: 19194306
[TBL] [Abstract][Full Text] [Related]
32. Features and toxicokinetics of clozapine in overdose.
Reith D; Monteleone JP; Whyte IM; Ebelling W; Holford NH; Carter GL
Ther Drug Monit; 1998 Feb; 20(1):92-7. PubMed ID: 9485562
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of clozapine and its metabolites in psychiatric patients: plasma protein binding and renal clearance.
Schaber G; Stevens I; Gaertner HJ; Dietz K; Breyer-Pfaff U
Br J Clin Pharmacol; 1998 Nov; 46(5):453-9. PubMed ID: 9833598
[TBL] [Abstract][Full Text] [Related]
34. Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993-2007.
Couchman L; Morgan PE; Spencer EP; Flanagan RJ
Ther Drug Monit; 2010 Aug; 32(4):438-47. PubMed ID: 20463634
[TBL] [Abstract][Full Text] [Related]
35. Effect of Valproate and Antidepressant Drugs on Clozapine Metabolism in Patients With Psychotic Mood Disorders.
Marazziti D; Palego L; Betti L; Giannaccini G; Massimetti E; Baroni S; Ciapparelli A; Lucacchini A; Mucci F; DellʼOsso L
Ther Drug Monit; 2018 Aug; 40(4):443-451. PubMed ID: 29601407
[TBL] [Abstract][Full Text] [Related]
36. Clozapine, norclozapine plasma levels, their sum and ratio in 50 psychotic patients: influence of patient-related variables.
Palego L; Biondi L; Giannaccini G; Sarno N; Elmi S; Ciapparelli A; Cassano GB; Lucacchini A; Martini C; Dell'Osso L
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):473-80. PubMed ID: 11999897
[TBL] [Abstract][Full Text] [Related]
37. Cytochrome P450 and therapeutic drug monitoring with respect to clozapine.
Buur-Rasmussen B; Brøsen K
Eur Neuropsychopharmacol; 1999 Dec; 9(6):453-9. PubMed ID: 10625111
[TBL] [Abstract][Full Text] [Related]
38. Increasing the clozapine: norclozapine ratio with co-administration of fluvoxamine to enhance efficacy and minimize side effects of clozapine therapy.
Légaré N; Grégoire CA; De Benedictis L; Dumais A
Med Hypotheses; 2013 Jun; 80(6):689-91. PubMed ID: 23490199
[TBL] [Abstract][Full Text] [Related]
39. Effect of influenza vaccination on serum clozapine and its main metabolite concentrations in patients with schizophrenia.
Raaska K; Raitasuo V; Neuvonen PJ
Eur J Clin Pharmacol; 2001 Dec; 57(10):705-8. PubMed ID: 11829199
[TBL] [Abstract][Full Text] [Related]
40. Increase in plasma levels of clozapine and norclozapine after administration of nefazodone.
Khan AY; Preskorn SH
J Clin Psychiatry; 2001 May; 62(5):375-6. PubMed ID: 11411823
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]